Research ArticleCANCER

Syrosingopine sensitizes cancer cells to killing by metformin

See allHide authors and affiliations

Science Advances  23 Dec 2016:
Vol. 2, no. 12, e1601756
DOI: 10.1126/sciadv.1601756

Article Information

vol. 2 no. 12

Online ISSN: 
History: 
  • Received for publication July 28, 2016
  • Accepted for publication October 20, 2016

Author Information

  1. Don Benjamin1,
  2. Marco Colombi1,
  3. Sravanth K. Hindupur1,
  4. Charles Betz1,
  5. Heidi A. Lane2,
  6. Mahmoud Y. M. El-Shemerly2,
  7. Min Lu3,
  8. Luca Quagliata4,
  9. Luigi Terracciano4,
  10. Suzette Moes1,
  11. Timothy Sharpe1,
  12. Aleksandra Wodnar-Filipowicz5,
  13. Christoph Moroni1 and
  14. Michael N. Hall1,*
  1. 1Biozentrum, University of Basel, 4056 Basel, Switzerland.
  2. 2Basilea Pharmaceutica International Ltd., Basel, Switzerland.
  3. 3Institute for Medical Microbiology, University of Basel, 4003 Basel, Switzerland.
  4. 4Molecular Pathology, University Hospital Basel, 4003 Basel, Switzerland.
  5. 5Stem Cell Center of Competence, University of Basel, 4056 Basel, Switzerland.
  1. *Corresponding author. Email: m.hall{at}unibas.ch

Altmetric

Article usage

Article usage: December 2016 to April 2019

AbstractFullPdf
Dec 2016749847861469
Jan 2017778097651933
Feb 2017701812457
Mar 2017489535581
Apr 2017368452197
May 2017980368181
Jun 2017235276161
Jul 2017225290187
Aug 2017199245179
Sep 2017222223119
Oct 201713715983
Nov 2017231250107
Dec 201716916079
Jan 2018172170121
Feb 20181118779
Mar 201815513894
Apr 20181269758
May 201815617432
Jun 201815116677
Jul 20189615236
Aug 2018037466
Sep 2018034990
Oct 2018027347
Nov 2018035552
Dec 20180884261
Jan 201911485173
Feb 2019733998
Mar 20198348118
Apr 2019522058

Navigate This Article